Protocol recommendations for administration of intravenous immunoglobulin in Canada.
A group of Canadian nurses and transfusion safety officers developed 10 recommendations for the infusion of intravenous immunoglobulin (IVIG) in acute care hospitals and clinics. The recommendations address issues related to documentation, patient consent, difference among IVIG brands, selection of a brand on the basis of patients' risk factors, contraindications, needs, action plans for adverse events, rapid infusion protocols, and setup of infusion pumps, tubing, and filter equipment. The Canadian group encouraged institutions to include nurses on committees that examine infusion protocols.
Reid
Brenda
B
The Hospital for Sick Children, Toronto, Ontario, Canada. brenda.reid@sickkids.ca
Van Allen
Donna
D
LaGrange
Carole Ann
CA
Boissonneault
Nathalie
N
D002170:Canada; D002985:Clinical Protocols; D004282:Documentation / Q000592:standards; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000627:therapeutic use*; D007258:Informed Consent / Q000592:standards; D007262:Infusions, Intravenous / Q000451:nursing / Q000592:standards; D024802:Nurse's Role; D009730:Nursing Assessment / Q000592:standards; D009737:Nursing Records / Q000592:standards; D010347:Patient Care Planning / Q000592:standards; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018570:Risk Assessment / Q000592:standards; D017751:Safety Management / Q000592:standards
D016756:Immunoglobulins, Intravenous